| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
|
Mediators Inflamm
|
2011
|
1.42
|
|
2
|
The roles of cells and cytokines in the pathogenesis of psoriasis.
|
Int J Dermatol
|
2012
|
1.14
|
|
3
|
Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats.
|
Med Sci Monit
|
2007
|
1.04
|
|
4
|
The effect of green tea in oxidative stress.
|
Clin Nutr
|
2006
|
1.03
|
|
5
|
Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood.
|
J Pregnancy
|
2012
|
1.02
|
|
6
|
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients.
|
Acta Haematol
|
2009
|
0.99
|
|
7
|
Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
|
J Clin Immunol
|
2008
|
0.97
|
|
8
|
Implication of low HDL-c levels in patients with average LDL-c levels: a focus on oxidized LDL, large HDL subpopulation, and adiponectin.
|
Mediators Inflamm
|
2013
|
0.91
|
|
9
|
Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients.
|
Am J Nephrol
|
2008
|
0.89
|
|
10
|
Markers of increased cardiovascular risk in postmenopausal women: focus on oxidized-LDL and HDL subpopulations.
|
Dis Markers
|
2013
|
0.88
|
|
11
|
Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients.
|
Br J Haematol
|
2010
|
0.87
|
|
12
|
Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis.
|
Blood Cells Mol Dis
|
2008
|
0.87
|
|
13
|
Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients.
|
Ren Fail
|
2013
|
0.86
|
|
14
|
Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
|
Am J Nephrol
|
2008
|
0.85
|
|
15
|
Fetal lipoprotein changes in pre-eclampsia.
|
Acta Obstet Gynecol Scand
|
2008
|
0.85
|
|
16
|
Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications.
|
Open Biochem J
|
2012
|
0.85
|
|
17
|
Bilirubin dependence on UGT1A1 polymorphisms, hemoglobin, fasting time and body mass index.
|
Am J Med Sci
|
2012
|
0.83
|
|
18
|
Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients.
|
Blood Cells Mol Dis
|
2010
|
0.82
|
|
19
|
Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses.
|
Hemodial Int
|
2013
|
0.82
|
|
20
|
Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease.
|
J Dermatol Sci
|
2009
|
0.80
|
|
21
|
Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene.
|
Hemodial Int
|
2012
|
0.80
|
|
22
|
Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.
|
Int J Mol Sci
|
2012
|
0.79
|
|
23
|
Changes in red blood cells membrane protein composition during hemodialysis procedure.
|
Ren Fail
|
2008
|
0.79
|
|
24
|
Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage.
|
J Perinat Med
|
2009
|
0.79
|
|
25
|
Impact of a School-Based Intervention Protocol - ACORDA Project - On Adipokines in An Overweight and Obese Pediatric Population.
|
Pediatr Exerc Sci
|
2016
|
0.78
|
|
26
|
Acitretin affects bioenergetics of liver mitochondria and promotes mitochondrial permeability transition: potential mechanisms of hepatotoxicity.
|
Toxicology
|
2013
|
0.78
|
|
27
|
Health-related quality of life in Portuguese psoriatic patients: relation with Psoriasis Area and Severity Index and different types of classical psoriatic treatment.
|
J Dermatol
|
2010
|
0.78
|
|
28
|
Main determinants of PON1 activity in hemodialysis patients.
|
Am J Nephrol
|
2012
|
0.78
|
|
29
|
DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis.
|
Acta Haematol
|
2008
|
0.77
|
|
30
|
Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
|
Am J Clin Dermatol
|
2010
|
0.77
|
|
31
|
Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy.
|
Blood Purif
|
2008
|
0.77
|
|
32
|
Comparison of Bio-Plex measurements with standard techniques.
|
Clin Chem Lab Med
|
2011
|
0.76
|
|
33
|
Hereditary spherocytosis and the (TA)nTAA polymorphism of UGT1A1 gene promoter region--a comparison of the bilirubin plasmatic levels in the different clinical forms.
|
Blood Cells Mol Dis
|
2010
|
0.76
|
|
34
|
Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
|
Am J Clin Dermatol
|
2012
|
0.76
|
|
35
|
Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
|
Am J Clin Dermatol
|
2013
|
0.75
|
|
36
|
Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis.
|
Scand J Urol Nephrol
|
2012
|
0.75
|
|
37
|
Factors associated with the length of remission of psoriasis vulgaris.
|
Clin Drug Investig
|
2013
|
0.75
|
|
38
|
IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy.
|
Blood Cells Mol Dis
|
2008
|
0.75
|
|
39
|
Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress.
|
Blood Cells Mol Dis
|
2009
|
0.75
|
|
40
|
Vascular access versus the effect of statins on inflammation and fibrinolysis in renal dialysis patients.
|
J Vasc Access
|
2013
|
0.75
|
|
41
|
Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A.
|
Int J Dermatol
|
2013
|
0.75
|
|
42
|
Letter to the editor: A potential mechanism for the pathogenesis of psoriasis vulgaris.
|
Int J Dermatol
|
2012
|
0.75
|
|
43
|
Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome.
|
Clin Biochem
|
2011
|
0.75
|
|
44
|
The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen.
|
J Bioenerg Biomembr
|
2013
|
0.75
|